The healthcare sector saw an influx of investments in the first quarter of 2017, according to The PwC/CB Insights MoneyTree™ Report. Data from that report found that the total amount of money invested in healthcare companies in the first quarter of 2017 rose to $3.719 billion, making it the second-largest industry arena for investments after the Internet sector.
Financing for the medical device and equipment sector rose sharply, from just $392 million invested in the space during the last quarter of 2016 to $677 million invested in the first quarter of this year. That’s the highest level since the third quarter of 2015. The number of deals in the medical device and equipment arena rose to 67, higher than any quarter in 2016.
These were the 10 largest venture capital investments in medical device and equipment companies during the first quarter of 2017.
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.
(Morning Call) – Medical device maker B. Braun concealed from regulators problems with its line of ceramic-coated artificial knees and promoted the products to surgeons despite knowing they were prone to fail, a lawsuit filed in a California court alleges. […]
Miach Orthopaedics, Inc., a privately held company dedicated to developing bio-engineered surgical implants for connective tissue repair, today announced study results showing that the Bridge-Enhanced® ACL Repair (BEAR®) procedure using the BEAR implant resulted in similar outcomes to traditional ACL reconstruction. […]
Be the first to comment